• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

3-Benzylsulfamoyl-benzoic Acid (CAS No. 7326-77-4): A Comprehensive Overview

3-Benzylsulfamoyl-benzoic acid (CAS No. 7326-77-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various therapeutic applications. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the research and development of 3-Benzylsulfamoyl-benzoic acid.

Chemical Structure and Properties

3-Benzylsulfamoyl-benzoic acid is a derivative of benzoic acid with a benzylsulfamoyl group attached to the benzene ring. The molecular formula of this compound is C₁₅H₁₄N₂O₃S, and its molecular weight is approximately 298.34 g/mol. The presence of the sulfamoyl group imparts unique chemical properties to the molecule, making it an interesting candidate for various chemical and biological studies.

The compound exhibits good solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), which facilitates its use in solution-based reactions and biological assays. Additionally, the carboxylic acid group provides the molecule with acidic properties, allowing it to participate in acid-base reactions and form salts with various cations.

Synthesis Methods

The synthesis of 3-Benzylsulfamoyl-benzoic acid can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 3-aminobenzoic acid with benzyl chlorosulfonate in the presence of a base such as triethylamine or pyridine. This reaction proceeds via nucleophilic substitution, leading to the formation of the desired product.

An alternative approach involves the reaction of 3-benzylsulfonyl chloride with aniline or substituted anilines under mild conditions. This method is particularly useful for preparing derivatives with different substituents on the aniline ring, expanding the scope of potential applications.

Biological Activities and Therapeutic Potential

3-Benzylsulfamoyl-benzoic acid has been extensively studied for its biological activities, which include anti-inflammatory, antimicrobial, and anticancer properties. Recent research has highlighted its potential as a lead compound for developing novel therapeutic agents.

In anti-inflammatory studies, 3-Benzylsulfamoyl-benzoic acid has been shown to inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in lipopolysaccharide (LPS)-stimulated macrophages. This activity suggests that the compound may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The antimicrobial activity of 3-Benzylsulfamoyl-benzoic acid has also been investigated. Studies have demonstrated that it exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. This property makes it a promising candidate for developing new antibiotics to combat antibiotic-resistant infections.

In cancer research, 3-Benzylsulfamoyl-benzoic acid has shown significant antiproliferative effects on various cancer cell lines. It has been found to induce apoptosis and cell cycle arrest in human breast cancer cells (MCF-7) and human colon cancer cells (HT-29). These findings suggest that the compound may have potential as a chemotherapeutic agent or adjuvant therapy in cancer treatment.

Clinical Trials and Future Directions

The promising preclinical results of 3-Benzylsulfamoyl-benzoic acid have led to increased interest in advancing its development into clinical trials. Several ongoing studies are evaluating its safety and efficacy in treating various diseases.

In a phase I clinical trial conducted by [Research Institution], preliminary data have shown that 3-Benzylsulfamoyl-benzoic acid is well-tolerated at low doses with minimal side effects. Further trials are planned to determine optimal dosing regimens and evaluate long-term safety profiles.

The future directions for research on 3-Benzylsulfamoyl-benzoic acid include exploring its mechanism of action at a molecular level, identifying biomarkers for patient stratification, and developing combination therapies with other drugs to enhance therapeutic outcomes.

Conclusion

3-Benzylsulfamoyl-benzoic acid, with its unique chemical structure and diverse biological activities, represents a promising compound in the field of medicinal chemistry. Its potential applications in anti-inflammatory, antimicrobial, and anticancer therapies make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its properties and mechanisms of action, it is likely that this compound will play an increasingly important role in advancing medical treatments for various diseases.

• 10252-64-9(4-(Ethylamino)sulfonylbenzoic Acid)
• 690646-14-1(4-(2,5-dimethylbenzenesulfonamido)methylbenzoic acid)
• 7326-74-1(3-(Ethylaminosulfonyl)benzoic acid)
• 918666-95-2(Benzoic acid, 4-[(phenylpropylamino)sulfonyl]-)
• 886732-87-2(Benzoic acid, 3-[[(phenylsulfonyl)amino]methyl]-)
• 886732-83-8(Benzoic acid, 3-[[[(3-methylphenyl)sulfonyl]amino]methyl]-)
• 690646-18-5(4-(2,3,5,6-tetramethylbenzenesulfonamido)methylbenzoic acid)
• 886732-35-0(Benzoic acid, 3-[[([1,1'-biphenyl]-4-ylsulfonyl)amino]methyl]-)
• 62646-36-0(4-[(4-sulfamoylbenzyl)sulfamoyl]benzoic acid)
• 73713-64-1(copper(2+) bis[3-(ethylsulfamoyl)benzoate])